FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383313117> ?p ?o ?g. }

• W4383313117 abstract "The COVID-19 pandemic has exacerbated mortality rates among immunocompromised patients, accentuating the need for novel, targeted therapies. Transplant recipients, with their inherent immune vulnerabilities, represent a subgroup at significantly heightened risk. Current conventional therapies often demonstrate limited effectiveness in these patients, calling for innovative treatment approaches. In immunocompromised transplant recipients, several viral infections have been successfully treated by adoptive transfer of virus-specific T-cells (VST). This paper details the successful application of SARS-CoV-2-specific memory T-cell therapy, produced by an interferon-γ cytokine capture system (CliniMACS® Prodigy device), in three stem cell transplant recipients diagnosed with COVID-19 (case 1: alpha variant, cases 2 and 3: delta variants). These patients exhibited persistent SARS-CoV-2 PCR positivity accompanied by bilateral pulmonary infiltrates and demonstrated only partial response to standard treatments. Remarkably, all three patients recovered and achieved viral clearance within 3 to 9 weeks post-VST treatment. Laboratory follow-up investigations identified an increase in SARS-CoV-2-specific T-cells in two of the cases. A robust anti-SARS-CoV-2 S (S1/S2) IgG serological response was also recorded, albeit with varying titers. The induction of memory T-cells within the CD4 + compartment was confirmed, and previously elevated interleukin-6 (IL-6) and IL-8 levels normalized post-VST therapy. The treatment was well tolerated with no observed adverse effects. While the need for specialized equipment and costs associated with VST therapy present potential challenges, the limited treatment options currently available for COVID-19 within the allogeneic stem cell transplant population, combined with the risk posed by emerging SARS-CoV-2 mutations, underscore the potential of VST therapy in future clinical practice. This therapeutic approach may be particularly beneficial for elderly patients with multiple comorbidities and weakened immune systems." @default.
• W4383313117 created "2023-07-07" @default.
• W4383313117 creator A5001299035 @default.
• W4383313117 creator A5012080747 @default.
• W4383313117 creator A5012507572 @default.
• W4383313117 creator A5018861454 @default.
• W4383313117 creator A5027021089 @default.
• W4383313117 creator A5029335382 @default.
• W4383313117 creator A5041765633 @default.
• W4383313117 creator A5046014777 @default.
• W4383313117 creator A5046329848 @default.
• W4383313117 creator A5048096846 @default.
• W4383313117 creator A5049676578 @default.
• W4383313117 creator A5051724283 @default.
• W4383313117 creator A5052619482 @default.
• W4383313117 creator A5060371076 @default.
• W4383313117 creator A5064640466 @default.
• W4383313117 creator A5066175900 @default.
• W4383313117 creator A5067418606 @default.
• W4383313117 creator A5070784673 @default.
• W4383313117 creator A5082857027 @default.
• W4383313117 creator A5087211110 @default.
• W4383313117 creator A5089444754 @default.
• W4383313117 creator A5091499320 @default.
• W4383313117 creator A5091732461 @default.
• W4383313117 creator A5092410027 @default.
• W4383313117 creator A5092410028 @default.
• W4383313117 date "2023-07-06" @default.
• W4383313117 modified "2023-10-15" @default.
• W4383313117 title "Effective virus-specific T-cell therapy for high-risk SARS-CoV-2 infections in hematopoietic stem cell transplant recipients: initial case studies and literature review" @default.
• W4383313117 cites W1737344958 @default.
• W4383313117 cites W2077105008 @default.
• W4383313117 cites W2088315315 @default.
• W4383313117 cites W2144737390 @default.
• W4383313117 cites W2340809593 @default.
• W4383313117 cites W2525681513 @default.
• W4383313117 cites W2744246163 @default.
• W4383313117 cites W2761374724 @default.
• W4383313117 cites W2774621607 @default.
• W4383313117 cites W2931249772 @default.
• W4383313117 cites W2971753110 @default.
• W4383313117 cites W2982395926 @default.
• W4383313117 cites W2991178688 @default.
• W4383313117 cites W3002361848 @default.
• W4383313117 cites W3015835940 @default.
• W4383313117 cites W3024493961 @default.
• W4383313117 cites W3029557269 @default.
• W4383313117 cites W3030378578 @default.
• W4383313117 cites W3036328466 @default.
• W4383313117 cites W3036385205 @default.
• W4383313117 cites W3036482760 @default.
• W4383313117 cites W3040758023 @default.
• W4383313117 cites W3048434629 @default.
• W4383313117 cites W3102798166 @default.
• W4383313117 cites W3111728581 @default.
• W4383313117 cites W3113409560 @default.
• W4383313117 cites W3119663014 @default.
• W4383313117 cites W3121748893 @default.
• W4383313117 cites W3122861027 @default.
• W4383313117 cites W3128847099 @default.
• W4383313117 cites W3130027029 @default.
• W4383313117 cites W3157803744 @default.
• W4383313117 cites W3162585659 @default.
• W4383313117 cites W3165091170 @default.
• W4383313117 cites W3166152977 @default.
• W4383313117 cites W3186868057 @default.
• W4383313117 cites W3187717873 @default.
• W4383313117 cites W3192993268 @default.
• W4383313117 cites W3195832814 @default.
• W4383313117 cites W3204565143 @default.
• W4383313117 cites W3209221616 @default.
• W4383313117 cites W3209376120 @default.
• W4383313117 cites W3209845668 @default.
• W4383313117 cites W3212827332 @default.
• W4383313117 cites W3215717783 @default.
• W4383313117 cites W4200220884 @default.
• W4383313117 cites W4200293390 @default.
• W4383313117 cites W4200327972 @default.
• W4383313117 cites W4210252764 @default.
• W4383313117 cites W4210257622 @default.
• W4383313117 cites W4210642183 @default.
• W4383313117 cites W4213138711 @default.
• W4383313117 cites W4214529002 @default.
• W4383313117 cites W4214832330 @default.
• W4383313117 cites W4223472707 @default.
• W4383313117 cites W4224219503 @default.
• W4383313117 cites W4226163566 @default.
• W4383313117 cites W4234763688 @default.
• W4383313117 cites W4283776454 @default.
• W4383313117 cites W4308873523 @default.
• W4383313117 cites W4309516074 @default.
• W4383313117 cites W4361865032 @default.
• W4383313117 cites W4366463615 @default.
• W4383313117 doi "https://doi.org/10.1007/s11357-023-00858-7" @default.
• W4383313117 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37414968" @default.
• W4383313117 hasPublicationYear "2023" @default.
• W4383313117 type Work @default.
• W4383313117 citedByCount "0" @default.
• W4383313117 crossrefType "journal-article" @default.
• W4383313117 hasAuthorship W4383313117A5001299035 @default.

• next